Wednesday, June 10, 2026

biotech · Neuroblastoma · Hyperinflammation, Sepsis · AXIM

AXIM Biotechnologies

News and analysis for AXIM Biotechnologies on NovaPharmaNews — regulatory, clinical, and market coverage.

18 East 50th Street, 5 Floor, New York, NY 10022, US HQ
2011 Founded
7 Employees
Public company Type
AXIM · NYSE Ticker
Company details
Status
Public
HQ
18 East 50th Street, 5 Floor, New York, NY 10022, US
Founded
2011
Employees
7
Programs
20
Drugs
52
Patents
138
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning AXIM Biotechnologies — regulatory, clinical, and market coverage.

News and analysis for AXIM Biotechnologies on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning AXIM Biotechnologies yet.

Back to company overview →